Yelena Yankovskaya, PharmD, Discusses the Expectations and Roles of VBID in Combating Nonadherence
Yelena Yankovskaya, PharmD, a managed markets fellow at the Mayes College of Healthcare Business and Policy, describes the expectations and roles of predictive modeling, value-based insurance design, and gamification/social media in contemporary managed care pharmacy.
This video was taken at the Academy of Managed Care Pharmacy's 25th Annual Meeting & Expo in San Diego, CA, on April 4, 2013.
Having people from different parts of the diabetes care equation talking together at the 3rd Annual Patient-Centered Diabetes Care Meeting is what will move the industry forward, according to Robert A. Gabbay, MD, PhD, chief medical officer and senior vice president at Joslin Diabetes Center and the editor-in-chief of Evidence-Based Diabetes Management journal.
Missouri already spends $1.2 billion on Medicaid managed care in less than half its counties. The new plan would extend managed care to all Medicaid clients except the blind, disabled, and elderly. Meanwhile, in North Carolina, the CEO of the Medical Society argued against moving Medicaid to managed care, citing problems in other states.
Recent emphasis of identifying those with prediabetes and intervening to halt its progression is aimed at reducing the financial impact of diabetes in the United States, which was estimated in 2012 at $245 billion.